Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 47Gynecologic 20CNS 10Lymphoid 5Breast 5Gastrointestinal 4Other neoplasm 3Genitourinary 3Other hematologic neoplasm 2Head & Neck 2Tumor-Agnostic 1Thoracic 1Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Leukoplakia 1Leukokeratosis, Hereditary Mucosal 1

Interventions

Cisplatin 619pembrolizumab 323Radiotherapy 319Cetuximab 274Docetaxel 220Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 74Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 48Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 43tislelizumab 42Standard of Care 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Imiquimod × Head & Neck × Clear all
NCT07210775 2026-03-04

Topical Imiquimod Treatment of Oral Dysplasia

University of Southern California

Phase 1/2 Recruiting
20 enrolled
DermatologicHead & Neck

Leukoplakia, Leukokeratosis, Hereditary Mucosal

NCT04883645 2025-01-28

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

Medical University of South Carolina

Phase EARLY_PHASE1 Completed
16 enrolled 10 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡